{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:02:44Z","timestamp":1773414164307,"version":"3.50.1"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-04926-5","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T09:04:57Z","timestamp":1770541497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stem cell-based therapies for alopecia areata: a narrative review"],"prefix":"10.1186","volume":"17","author":[{"given":"Aiping","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"issue":"3","key":"4926_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","volume":"82","author":"HH Lee","year":"2020","unstructured":"Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, et al. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;82(3):675\u201382.","journal-title":"J Am Acad Dermatol"},{"key":"4926_CR2","doi-asserted-by":"crossref","unstructured":"Strazzulla LC, Wang EHC, Avila L, Sicco KL, Brinster N, Christiano AM et al. Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J AM ACAD DERMATOL. 2018;78(1).","DOI":"10.1016\/j.jaad.2017.04.1141"},{"issue":"3","key":"4926_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jaad.2018.01.048","volume":"79","author":"LY Liu","year":"2018","unstructured":"Liu LY, King BA, Craiglow BG. Alopecia areata is associated with impaired health-related quality of life: a survey of affected adults and children and their families. J Am Acad Dermatol. 2018;79(3):556-558.e1.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4926_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/bjd.14497","volume":"175","author":"F Rencz","year":"2016","unstructured":"Rencz F, Gul\u00e1csi L, P\u00e9ntek M, Wikonk\u00e1l N, Baji P, Brodszky V. Alopecia areata and health-related quality of life: a systematic review and meta\u2010analysis. Br J Dermatol. 2016;175(3):561\u201371.","journal-title":"Br J Dermatol"},{"issue":"3","key":"4926_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12016-021-08883-0","volume":"61","author":"C Zhou","year":"2021","unstructured":"Zhou C, Li X, Wang C, Zhang J. Alopecia areata: what\u2019s new in the etiopathogenesis, diagnosis, and management? Clin Rev Allerg Immunol. 2021;61(3):403\u201323.","journal-title":"Clin Rev Allerg Immunol"},{"issue":"3","key":"4926_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jdermsci.2023.09.008","volume":"112","author":"T Dainichi","year":"2023","unstructured":"Dainichi T, Iwata M, Kaku Y. Alopecia areata: what\u2019s new in the epidemiology, comorbidities, and pathogenesis? J Dermatol Sci. 2023;112(3):120\u20137.","journal-title":"J Dermatol Sci"},{"key":"4926_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1181572","volume":"10","author":"Y Ma","year":"2023","unstructured":"Ma Y, Sun Z, Li YM, Xu H. Oxidative stress and alopecia areata. Front Med. 2023;10:1181572.","journal-title":"Front Med"},{"issue":"1","key":"4926_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/bmb\/ldr012","volume":"98","author":"D Ilic","year":"2011","unstructured":"Ilic D, Polak JM. Stem cells in regenerative medicine: introduction. Br Med Bull. 2011;98(1):117\u201326.","journal-title":"Br Med Bull"},{"issue":"8","key":"4926_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080886","volume":"8","author":"Y Han","year":"2019","unstructured":"Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8(8):886.","journal-title":"Cells"},{"issue":"1","key":"4926_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3727\/096368910X","volume":"20","author":"DC Ding","year":"2011","unstructured":"Ding DC, Shyu WC, Lin SZ. Mesenchymal Stem Cells. Cell Transplant. 2011;20(1):5\u201314.","journal-title":"Cell Transplant"},{"issue":"6","key":"4926_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41423-023-01022-z","volume":"20","author":"N Kadri","year":"2023","unstructured":"Kadri N, Amu S, Iacobaeus E, Boberg E, Le Blanc K. Current perspectives on mesenchymal stromal cell therapy for graft versus host disease. Cell Mol Immunol. 2023;20(6):613\u201325.","journal-title":"Cell Mol Immunol"},{"issue":"9419","key":"4926_CR12","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, G\u00f6therstr\u00f6m C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363(9419):1439\u201341.","journal-title":"Lancet"},{"key":"4926_CR13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3389\/fimmu.2019.00798","volume":"10","author":"N Luque-Campos","year":"2019","unstructured":"Luque-Campos N, Contreras-L\u00f3pez RA, Jose Paredes-Mart\u00ednez M, Torres MJ, Bahraoui S, Wei M, et al. Mesenchymal stem cells improve rheumatoid arthritis progression by controlling memory T cell response. Front Immunol. 2019;10:798.","journal-title":"Front Immunol"},{"issue":"1","key":"4926_CR14","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1182\/blood-2004-01-0136","volume":"105","author":"B Seifert","year":"2005","unstructured":"Seifert B, Passweg JR, Heim D, Rov\u00f3 A, Meyer-Monard S, Buechner S, et al. Complete remission of alopecia universalis after allogeneic hematopoietic stem cell transplantation. Blood. 2005;105(1):426\u20137.","journal-title":"Blood"},{"issue":"16","key":"4926_CR15","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1056\/NEJMra1103442","volume":"366","author":"A Gilhar","year":"2012","unstructured":"Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012;366(16):1515\u201325.","journal-title":"N Engl J Med"},{"issue":"1","key":"4926_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.11","volume":"3","author":"CH Pratt","year":"2017","unstructured":"Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):17011.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"4926_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/exd.14155","volume":"29","author":"M Bertolini","year":"2020","unstructured":"Bertolini M, McElwee K, Gilhar A, Bulfone-Paus S, Paus R. Hair follicle immune privilege and its collapse in alopecia areata. Exp Dermatol. 2020;29(8):703\u201325.","journal-title":"Exp Dermatol"},{"issue":"5","key":"4926_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/bjd.16808","volume":"179","author":"F Rajabi","year":"2018","unstructured":"Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018;179(5):1033\u201348.","journal-title":"Br J Dermatol"},{"issue":"1","key":"4926_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.immuni.2007.05.016","volume":"27","author":"MJ Butte","year":"2007","unstructured":"Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 2007;27(1):111\u201322.","journal-title":"Immunity"},{"issue":"3","key":"4926_CR20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/jid.2013.368","volume":"134","author":"X Wang","year":"2014","unstructured":"Wang X, Marr AK, Breitkopf T, Leung G, Hao J, Wang E, et al. Hair follicle mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege. J Invest Dermatol. 2014;134(3):736\u201345.","journal-title":"J Invest Dermatol"},{"key":"4926_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1600-065X.2006.00430.x","volume":"213","author":"TA Ferguson","year":"2006","unstructured":"Ferguson TA, Griffith TS. A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol Rev. 2006;213:228\u201338.","journal-title":"Immunol Rev"},{"issue":"2","key":"4926_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","volume":"164","author":"T Ito","year":"2004","unstructured":"Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol. 2004;164(2):623\u201334.","journal-title":"Am J Pathol"},{"issue":"11","key":"4926_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115652","volume":"25","author":"I \u0160uti\u0107 Udovi\u0107","year":"2024","unstructured":"\u0160uti\u0107 Udovi\u0107 I, Hla\u010da N, Massari LP, Brajac I, Ka\u0161telan M, Vi\u010di\u0107 M. Deciphering the complex immunopathogenesis of alopecia areata. Int J Mol Sci. 2024;25(11):5652.","journal-title":"Int J Mol Sci"},{"issue":"23","key":"4926_CR24","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1089\/scd.2016.0137","volume":"25","author":"P Mohammadi","year":"2016","unstructured":"Mohammadi P, Youssef KK, Abbasalizadeh S, Baharvand H, Aghdami N. Human hair reconstruction: close, but yet so far. Stem Cells Dev. 2016;25(23):1767\u201379.","journal-title":"Stem Cells Dev"},{"issue":"7","key":"4926_CR25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.autrev.2016.03.008","volume":"15","author":"A Gilhar","year":"2016","unstructured":"Gilhar A, Schrum AG, Etzioni A, Waldmann H, Paus R. Alopecia areata: animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies. Autoimmun Rev. 2016;15(7):726\u201335.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"4926_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nm.3645","volume":"20","author":"L Xing","year":"2014","unstructured":"Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med. 2014;20(9):1043\u20139.","journal-title":"Nat Med"},{"issue":"5","key":"4926_CR27","doi-asserted-by":"publisher","first-page":"e94260","DOI":"10.1371\/journal.pone.0094260","volume":"9","author":"M Bertolini","year":"2014","unstructured":"Bertolini M, Zilio F, Rossi A, Kleditzsch P, Emelianov VE, Gilhar A, et al. Abnormal interactions between perifollicular mast cells and CD8\u2009+\u2009T-cells may contribute to the pathogenesis of alopecia areata. PLoS One. 2014;9(5):e94260.","journal-title":"PLoS One"},{"issue":"6","key":"4926_CR28","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jaci.2019.08.035","volume":"144","author":"A Gilhar","year":"2019","unstructured":"Gilhar A, Laufer-Britva R, Keren A, Paus R. Frontiers in alopecia areata pathobiology research. J Allergy Clin Immunol. 2019;144(6):1478\u201389.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"4926_CR29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.0022-202X.2005.23692.x","volume":"124","author":"KJ McElwee","year":"2005","unstructured":"McElwee KJ, Freyschmidt-Paul P, Hoffmann R, Kissling S, Hummel S, Vitacolonna M, et al. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)\/CD25(-) cells promote systemic alopecia areata and CD4(+)\/CD25(+) cells blockade disease onset in the C3H\/HeJ mouse model. J Invest Dermatol. 2005;124(5):947\u201357.","journal-title":"J Invest Dermatol"},{"key":"4926_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00863-6","volume":"29","author":"O Salhab","year":"2022","unstructured":"Salhab O, Khayat L, Alaaeddine N. Stem cell secretome as a mechanism for restoring hair loss due to stress, particularly alopecia areata: narrative review. J Biomed Sci. 2022;29:77.","journal-title":"J Biomed Sci"},{"issue":"6","key":"4926_CR31","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/jdv.14775","volume":"32","author":"SH Loh","year":"2018","unstructured":"Loh SH, Moon HN, Lew BL, Sim WY. Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients. J Eur Acad Dermatol Venereol. 2018;32(6):1028\u201333.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"4926_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jdermsci.2013.01.006","volume":"70","author":"BS Shin","year":"2013","unstructured":"Shin BS, Furuhashi T, Nakamura M, Torii K, Morita A. Impaired inhibitory function of circulating CD4\u2009+\u2009CD25+ regulatory T cells in alopecia areata. J Dermatol Sci. 2013;70(2):141\u20133.","journal-title":"J Dermatol Sci"},{"issue":"7","key":"4926_CR33","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1001\/jamadermatol.2014.504","volume":"150","author":"E Castela","year":"2014","unstructured":"Castela E, Le Duff F, Butori C, Ticchioni M, Hofman P, Bahadoran P, et al. Effects of low-dose recombinant interleukin 2 to promote T-regulatory cells in alopecia areata. JAMA Dermatol. 2014;150(7):748\u201351.","journal-title":"JAMA Dermatol"},{"issue":"4","key":"4926_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1468-3083.2010.03799.x","volume":"25","author":"N Abdel Fattah","year":"2011","unstructured":"Abdel Fattah N, Ebrahim A, El Okda E. Lipid peroxidation\/antioxidant activity in patients with alopecia areata. J Eur Acad Dermatol Venereol. 2011;25(4):403\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"4926_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/ced.12556","volume":"40","author":"JZ Yenin","year":"2015","unstructured":"Yenin JZ, Serarslan G, Y\u00f6nden Z, Uluta\u015f KT. Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern. Clin Exp Dermatol. 2015;40(6):617\u201321.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"4926_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/ijd.14753","volume":"59","author":"P Acharya","year":"2020","unstructured":"Acharya P, Mathur MC. Oxidative stress in alopecia areata: a systematic review and meta-analysis. Int J Dermatol. 2020;59(4):434\u201340.","journal-title":"Int J Dermatol"},{"issue":"3","key":"4926_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","volume":"51","author":"EA Olsen","year":"2004","unstructured":"Olsen EA, Hordinsky MK, Price VH, Roberts JL, Shapiro J, Canfield D, et al. Alopecia areata investigational assessment guidelines\u2013Part II. J Am Acad Dermatol. 2004;51(3):440\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4926_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","volume":"78","author":"LC Strazzulla","year":"2018","unstructured":"Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, et al. Alopecia areata: an appraisal of new treatment approaches and overview of current therapies. J Am Acad Dermatol. 2018;78(1):15\u201324.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4926_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1365-2133.1973.tb06672.x","volume":"88","author":"E Abell","year":"1973","unstructured":"Abell E, Munro DD. Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol. 1973;88(1):55\u20139.","journal-title":"Br J Dermatol"},{"issue":"10","key":"4926_CR40","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/jamadermatol.2018.2312","volume":"154","author":"S Lee","year":"2018","unstructured":"Lee S, Kim BJ, Lee YB, Lee WS. Hair regrowth outcomes of contact immunotherapy for patients with alopecia areata: a systematic review and meta-analysis. JAMA Dermatol. 2018;154(10):1145\u201351.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"4926_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.11","volume":"3","author":"CH Pratt","year":"2017","unstructured":"Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):1\u201317.","journal-title":"Nat Rev Dis Primers"},{"key":"4926_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000336185","volume":"51","author":"J Kruh","year":"2012","unstructured":"Kruh J, Foster CS. Corticosteroid-sparing agents: conventional systemic immunosuppressants. Dev Ophthalmol. 2012;51:29\u201346.","journal-title":"Dev Ophthalmol"},{"issue":"1","key":"4926_CR43","first-page":"e78298","volume":"17","author":"YA Abarca","year":"2025","unstructured":"Abarca YA, Scott-Emuakpor R, Tirth J, Moroz O, Thomas GP, Yateem D, et al. Alopecia areata: understanding the pathophysiology and advancements in treatment modalities. Cureus. 2025;17(1):e78298.","journal-title":"Cureus"},{"issue":"5","key":"4926_CR44","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jdv.15489","volume":"33","author":"K Phan","year":"2019","unstructured":"Phan K, Sebaratnam D. f. JAK inhibitors for alopecia areata: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2019;33(5):850\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4926_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106359","volume":"183","author":"M Benucci","year":"2022","unstructured":"Benucci M, Damiani A, Infantino M, Manfredi M, Lari B, Grossi V, et al. Cardiovascular safety, cancer and Jak-inhibitors: differences to be highlighted. Pharmacol Res. 2022;183:106359.","journal-title":"Pharmacol Res"},{"issue":"11","key":"4926_CR46","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1007\/s10067-021-05911-4","volume":"40","author":"S Mori","year":"2021","unstructured":"Mori S, Ogata F, Tsunoda R. Risk of venous thromboembolism associated with Janus kinase inhibitors for rheumatoid arthritis: case presentation and literature review. Clin Rheumatol. 2021;40(11):4457\u201371.","journal-title":"Clin Rheumatol"},{"issue":"10169","key":"4926_CR47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(18)32987-8","volume":"393","author":"A Gilhar","year":"2019","unstructured":"Gilhar A, Keren A, Paus R. JAK inhibitors and alopecia areata. Lancet. 2019;393(10169):318\u20139.","journal-title":"Lancet"},{"issue":"6","key":"4926_CR48","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/exd.13255","volume":"26","author":"JW Byun","year":"2017","unstructured":"Byun JW, Kim HJ, Na K, Ko HS, Song HJ, Song SU, et al. Bone marrow-derived mesenchymal stem cells prevent alopecia areata development through the inhibition of NKG2D expression: a pilot study. Exp Dermatol. 2017;26(6):532\u20135.","journal-title":"Exp Dermatol"},{"issue":"1","key":"4926_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12916-015-0331-6","volume":"13","author":"Y Li","year":"2015","unstructured":"Li Y, Yan B, Wang H, Li H, Li Q, Zhao D, et al. Hair regrowth in alopecia areata patients following Stem Cell Educator therapy. BMC Med. 2015;13(1):87.","journal-title":"BMC Med"},{"key":"4926_CR50","doi-asserted-by":"publisher","unstructured":"Park SH, Song SW, Lee YJ, Kang H, Kim JE. Mesenchymal stem cell therapy in alopecia areata: visual and molecular evidence from a mouse model. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25179236.","DOI":"10.3390\/ijms25179236"},{"issue":"2","key":"4926_CR51","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jdermsci.2007.08.004","volume":"49","author":"WS Kim","year":"2008","unstructured":"Kim WS, Park BS, Kim HK, Park JS, Kim KJ, Choi JS, et al. Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci. 2008;49(2):133\u201342.","journal-title":"J Dermatol Sci"},{"issue":"7","key":"4926_CR52","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2174\/1574888X12666170829161058","volume":"12","author":"CH Won","year":"2017","unstructured":"Won CH, Park GH, Wu X, Tran TN, Park K, Park BS, et al. The basic mechanism of hair growth stimulation by adipose-derived stem cells and their secretory factors. Curr Stem Cell Res Ther. 2017;12(7):535\u201343.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"3","key":"4926_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14030612","volume":"14","author":"TC Anudeep","year":"2022","unstructured":"Anudeep TC, Jeyaraman M, Muthu S, Rajendran RL, Gangadaran P, Mishra PC, et al. Advancing regenerative cellular therapies in non-scarring alopecia. Pharmaceutics. 2022;14(3):612.","journal-title":"Pharmaceutics"},{"issue":"9","key":"4926_CR54","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci. 2020;41(9):653\u201364.","journal-title":"Trends Pharmacol Sci"},{"key":"4926_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00645","volume":"9","author":"F Carty","year":"2018","unstructured":"Carty F, Corbett JM, Cunha JPMCM, Reading JL, Tree TIM, Ting AE, et al. Multipotent adult progenitor cells suppress T cell activation in in vivo models of homeostatic proliferation in a prostaglandin E2-dependent manner. Front Immunol. 2018;9:645.","journal-title":"Front Immunol"},{"issue":"5","key":"4926_CR56","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jcyt.2018.02.003","volume":"20","author":"Q Guan","year":"2018","unstructured":"Guan Q, Li Y, Shpiruk T, Bhagwat S, Wall DA. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells. Cytotherapy. 2018;20(5):639\u201349.","journal-title":"Cytotherapy"},{"issue":"11","key":"4926_CR57","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/stem.2437","volume":"34","author":"J Tang","year":"2016","unstructured":"Tang J, Yang R, Lv L, Yao A, Pu L, Yin A, et al. Transforming growth factor-\u03b2-expressing mesenchymal stem cells induce local tolerance in a rat liver transplantation model of acute rejection. Stem Cells. 2016;34(11):2681\u201392.","journal-title":"Stem Cells"},{"issue":"1\u20132","key":"4926_CR58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cellimm.2012.02.004","volume":"274","author":"N Che","year":"2012","unstructured":"Che N, Li X, Zhou S, Liu R, Shi D, Lu L, et al. Umbilical cord mesenchymal stem cells suppress B-cell proliferation and differentiation. Cell Immunol. 2012;274(1\u20132):46\u201353.","journal-title":"Cell Immunol"},{"issue":"1","key":"4926_CR59","volume":"2015","author":"ME Castro-Manrreza","year":"2015","unstructured":"Castro-Manrreza ME, Montesinos JJ. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications. J Immunol Res. 2015;2015(1):394917.","journal-title":"J Immunol Res"},{"issue":"21","key":"4926_CR60","doi-asserted-by":"publisher","first-page":"13228","DOI":"10.3390\/ijms232113228","volume":"23","author":"JE Kim","year":"2022","unstructured":"Kim JE, Lee YJ, Lee KJ, Park SH, Kang H. Ex vivo treatment with allogenic mesenchymal stem cells of a healthy donor on peripheral blood mononuclear cells of patients with severe alopecia areata: targeting dysregulated T cells and the acquisition of immunotolerance. Int J Mol Sci. 2022;23(21):13228.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4926_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1741-7015-10-3","volume":"10","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Jiang Z, Zhao T, Ye M, Hu C, Yin Z, et al. Reversal of type 1 diabetes via islet \u03b2 cell regeneration following immune modulation by cord blood-derived multipotent stem cells. BMC Med. 2012;10(1):3.","journal-title":"BMC Med"},{"issue":"1","key":"4926_CR62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13287-024-04051-1","volume":"15","author":"W Yan","year":"2024","unstructured":"Yan W, Liu J, Xie X, Jin Q, Yang Y, Pan Y, et al. Restoration of follicular \u03b2-catenin signaling by mesenchymal stem cells promotes hair growth in mice with androgenetic alopecia. Stem Cell Res Ther. 2024;15(1):439.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"4926_CR63","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.devcel.2010.01.016","volume":"18","author":"D Enshell-Seijffers","year":"2010","unstructured":"Enshell-Seijffers D, Lindon C, Kashiwagi M, Morgan BA. \u03b2-catenin activity in the dermal papilla regulates morphogenesis and regeneration of hair. Dev Cell. 2010;18(4):633\u201342.","journal-title":"Dev Cell"},{"issue":"12","key":"4926_CR64","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/exd.12827","volume":"24","author":"KM Sohn","year":"2015","unstructured":"Sohn KM, Jeong KH, Kim JE, Park YM, Kang H. Hair growth-promotion effects of different alternating current parameter settings are mediated by the activation of Wnt\/\u03b2-catenin and MAPK pathway. Exp Dermatol. 2015;24(12):958\u201363.","journal-title":"Exp Dermatol"},{"issue":"4","key":"4926_CR65","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/exd.12335","volume":"23","author":"R Watabe","year":"2014","unstructured":"Watabe R, Yamaguchi T, Kabashima-Kubo R, Yoshioka M, Nishio D, Nakamura M. Leptin controls hair follicle cycling. Exp Dermatol. 2014;23(4):228\u20139.","journal-title":"Exp Dermatol"},{"issue":"9","key":"4926_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094581","volume":"22","author":"YJ Lee","year":"2021","unstructured":"Lee YJ, Park SH, Park HR, Lee Y, Kang H, Kim JE. Mesenchymal stem cells antagonize IFN-induced proinflammatory changes and growth inhibition effects via Wnt\/\u03b2-catenin and JAK\/STAT pathway in human outer root sheath cells and hair follicles. Int J Mol Sci. 2021;22(9):4581.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4926_CR67","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/exd.13812","volume":"29","author":"JE Kim","year":"2020","unstructured":"Kim JE, Oh JH, Woo YJ, Jung JH, Jeong KH, Kang H. Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models. Exp Dermatol. 2020;29(3):265\u201372.","journal-title":"Exp Dermatol"},{"issue":"2","key":"4926_CR68","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jdermsci.2009.10.013","volume":"57","author":"CH Won","year":"2010","unstructured":"Won CH, Yoo HG, Kwon OS, Sung MY, Kang YJ, Chung JH, et al. Hair growth promoting effects of adipose tissue-derived stem cells. J Dermatol Sci. 2010;57(2):134\u20137.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"4926_CR69","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cbin.12099","volume":"48","author":"S Hu","year":"2024","unstructured":"Hu S, Zhang J, Ji Q, Xie S, Jiang J, Ni H, et al. Exosomes derived from uMSCs promote hair regrowth in alopecia areata through accelerating human hair follicular keratinocyte proliferation and migration. Cell Biol Int. 2024;48(2):154\u201361.","journal-title":"Cell Biol Int"},{"issue":"1","key":"4926_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/srep05432","volume":"4","author":"L Dong","year":"2014","unstructured":"Dong L, Hao H, Xia L, Liu J, Ti D, Tong C, et al. Treatment of MSCs with Wnt1a-conditioned medium activates DP cells and promotes hair follicle regrowth. Sci Rep. 2014;4(1):5432.","journal-title":"Sci Rep"},{"issue":"3","key":"4926_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030893","volume":"12","author":"N Natarelli","year":"2023","unstructured":"Natarelli N, Gahoonia N, Sivamani RK. Integrative and mechanistic approach to the hair growth cycle and hair loss. J Clin Med. 2023;12(3):893.","journal-title":"J Clin Med"},{"issue":"4","key":"4926_CR72","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1172\/JCI11317","volume":"107","author":"K Yano","year":"2001","unstructured":"Yano K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest. 2001;107(4):409\u201317.","journal-title":"J Clin Invest"},{"key":"4926_CR73","doi-asserted-by":"publisher","DOI":"10.3727\/096368910X520065","author":"C Nie","year":"2011","unstructured":"Nie C, Yang D, Xu J, Si Z, Jin X, Zhang J. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant. 2011. https:\/\/doi.org\/10.3727\/096368910X520065.","journal-title":"Cell Transplant"},{"issue":"10","key":"4926_CR74","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1161\/01.CIR.0000121425.42966.F1","volume":"109","author":"J Rehman","year":"2004","unstructured":"Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109(10):1292\u20138.","journal-title":"Circulation"},{"issue":"12","key":"4926_CR75","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1161\/01.ATV.0000190701.92007.6d","volume":"25","author":"H Nakagami","year":"2005","unstructured":"Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol. 2005;25(12):2542\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"4926_CR76","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1292\/jvms.16-0122","volume":"78","author":"A Lee","year":"2016","unstructured":"Lee A, Bae S, Lee SH, Kweon OK, Kim WH. Hair growth promoting effect of dermal papilla like tissues from canine adipose-derived mesenchymal stem cells through vascular endothelial growth factor. J Vet Med Sci. 2016;78(12):1811\u20138.","journal-title":"J Vet Med Sci"},{"issue":"4","key":"4926_CR77","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.fsc.2018.06.010","volume":"26","author":"GK Epstein","year":"2018","unstructured":"Epstein GK, Epstein JS. Mesenchymal stem cells and stromal vascular fraction for hair loss: current status. Facial Plast Surg Clin North Am. 2018;26(4):503\u201311.","journal-title":"Facial Plast Surg Clin North Am"},{"key":"4926_CR78","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/132069","author":"A Czarnecka","year":"2021","unstructured":"Czarnecka A, Odziomek A, Murzyn M, Dubis J, Bag\u0142aj-Oleszczuk M, Hryncewicz-Gw\u00f3\u017ad\u017a A. Wharton\u2019s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata. Adv Clin Exp Med. 2021. https:\/\/doi.org\/10.17219\/acem\/132069.","journal-title":"Adv Clin Exp Med"},{"key":"4926_CR79","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i15.3741","author":"H Ahn","year":"2021","unstructured":"Ahn H, Lee SY, Jung WJ, Lee KH. Alopecia treatment using minimally manipulated human umbilical cord-derived mesenchymal stem cells: three case reports and review of literature. World J Clin Cases. 2021. https:\/\/doi.org\/10.12998\/wjcc.v9.i15.3741.","journal-title":"World J Clin Cases"},{"key":"4926_CR80","doi-asserted-by":"crossref","unstructured":"Anderi R. Cellular therapy with human autologous adipose-derived adult cells of stromal vascular fraction for alopecia areata. 2018.","DOI":"10.1186\/s13287-018-0889-y"},{"issue":"5","key":"4926_CR81","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1080\/09546634.2016.1227419","volume":"29","author":"IH Elmaadawi","year":"2018","unstructured":"Elmaadawi IH, Mohamed BM, Ibrahim ZAS, Abdou SM, El Attar YA, Youssef A, et al. Stem cell therapy as a novel therapeutic intervention for resistant cases of alopecia areata and androgenetic alopecia. J Dermatolog Treat. 2018;29(5):431\u201340.","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"4926_CR82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/01.EWX.0000392821.51950.e3","volume":"8","author":"MM Fawzy","year":"2011","unstructured":"Fawzy MM, Gabr HM, El Maadawi ZM. Autologous progenitor cell implantation as a novel therapeutic intervention for alopecia areata: Journal of the Egyptian Women\u02bcs Dermatologic Society. Journal of the Egyptian Women\u02bcs Dermatologic Society. 2011;8(1):11\u20136.","journal-title":"Journal of the Egyptian Women\u02bcs Dermatologic Society"},{"key":"4926_CR83","unstructured":"Mahmood A. Mesenchymal stem cell conditioned media induces hair regeneration in alopecia areata: A case study. 2021;5(1)."},{"key":"4926_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02252-9","author":"SB Lee","year":"2022","unstructured":"Lee SB. Clinical efficacy of adipocyte-derived stem cells conditioned media combined with micro-injury in refractory patch of alopecia areata. Arch Dermatol Res. 2022. https:\/\/doi.org\/10.1007\/s00403-021-02252-9.","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"4926_CR85","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s40261-023-01260-z","volume":"43","author":"M Papierzewska","year":"2023","unstructured":"Papierzewska M, Wa\u015bkiel-Burnat A, Rudnicka L. Safety of Janus kinase inhibitors in patients with alopecia areata: a systematic review. Clin Drug Investig. 2023;43(5):325\u201334.","journal-title":"Clin Drug Investig"},{"issue":"1","key":"4926_CR86","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s13287-023-03587-y","volume":"14","author":"J Li","year":"2023","unstructured":"Li J, Wu Z, Zhao L, Liu Y, Su Y, Gong X, et al. The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy. Stem Cell Res Ther. 2023;14(1):381.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"4926_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060951","volume":"12","author":"K Krefft-Trzciniecka","year":"2023","unstructured":"Krefft-Trzciniecka K, Pi\u0119towska Z, Nowicka D, Szepietowski JC. Human stem cell use in androgenetic alopecia: a systematic review. Cells. 2023;12(6):951.","journal-title":"Cells"},{"key":"4926_CR88","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1049641","volume":"2018","author":"A Owczarczyk-Saczonek","year":"2018","unstructured":"Owczarczyk-Saczonek A, Krajewska-W\u0142odarczyk M, Kruszewska A, Banasiak \u0141, Placek W, Maksymowicz W, et al. Therapeutic potential of stem cells in follicle regeneration. Stem Cells Int. 2018;2018:1049641.","journal-title":"Stem Cells Int"},{"issue":"9","key":"4926_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091852","volume":"18","author":"FJ Vizoso","year":"2017","unstructured":"Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18(9):1852.","journal-title":"Int J Mol Sci"},{"key":"4926_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173197","author":"AR Yuan","year":"2020","unstructured":"Yuan AR. Current advances in stem cell-based therapies for hair regeneration. Eur J Pharmacol. 2020. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173197.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4926_CR91","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.scib.2023.12.006","volume":"69","author":"J Wang","year":"2024","unstructured":"Wang J, Zhang X, Chen H, Ren H, Zhou M, Zhao Y. Engineered stem cells by emerging biomedical stratagems. Sci Bull. 2024;69(2):248\u201379.","journal-title":"Sci Bull"},{"issue":"12","key":"4926_CR92","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/cns.13754","volume":"27","author":"G Li","year":"2021","unstructured":"Li G, Liu J, Guan Y, Ji X. The role of hypoxia in stem cell regulation of the central nervous system: from embryonic development to adult proliferation. CNS Neurosci Ther. 2021;27(12):1446\u201357.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"4926_CR93","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/art.38206","volume":"66","author":"O Parolini","year":"2014","unstructured":"Parolini O, Souza-Moreira L, O\u2019Valle F, Magatti M, Hernandez-Cortes P, Gonzalez-Rey E, et al. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders. Arthritis Rheumatol. 2014;66(2):327\u201339.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"4926_CR94","doi-asserted-by":"publisher","first-page":"e113936","DOI":"10.1371\/journal.pone.0113936","volume":"9","author":"S Llufriu","year":"2014","unstructured":"Llufriu S, Sep\u00falveda M, Blanco Y, Mar\u00edn P, Moreno B, Berenguer J, et al. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. PLoS One. 2014;9(12):e113936.","journal-title":"PLoS One"},{"issue":"10","key":"4926_CR95","doi-asserted-by":"publisher","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7(10):e47559.","journal-title":"PLoS One"},{"issue":"5","key":"4926_CR96","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3109\/14653249.2010.507330","volume":"12","author":"DJ Prockop","year":"2010","unstructured":"Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, et al. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy. 2010;12(5):576\u20138.","journal-title":"Cytotherapy"},{"issue":"10","key":"4926_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102406","volume":"20","author":"S Neri","year":"2019","unstructured":"Neri S. Genetic stability of mesenchymal stromal cells for regenerative medicine applications: a fundamental biosafety aspect. Int J Mol Sci. 2019;20(10):2406.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4926_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/scrt138","volume":"3","author":"S Redaelli","year":"2012","unstructured":"Redaelli S, Bentivegna A, Foudah D, Miloso M, Redondo J, Riva G, et al. From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther. 2012;3(6):47.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"4926_CR99","doi-asserted-by":"publisher","first-page":"e77895","DOI":"10.1371\/journal.pone.0077895","volume":"8","author":"S Neri","year":"2013","unstructured":"Neri S, Bourin P, Peyrafitte JA, Cattini L, Facchini A, Mariani E. Human adipose stromal cells (ASC) for the regeneration of injured cartilage display genetic stability after in vitro culture expansion. PLoS One. 2013;8(10):e77895.","journal-title":"PLoS One"},{"issue":"12","key":"4926_CR100","doi-asserted-by":"publisher","first-page":"30015","DOI":"10.3390\/ijms161226215","volume":"16","author":"KJ Rhee","year":"2015","unstructured":"Rhee KJ, Lee JI, Eom YW. Mesenchymal stem cell-mediated effects of tumor support or suppression. Int J Mol Sci. 2015;16(12):30015\u201333.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4926_CR101","doi-asserted-by":"publisher","first-page":"e950","DOI":"10.1038\/cddis.2013.480","volume":"4","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhang Z, Chi Y, Zhang Q, Xu F, Yang Z, et al. Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation. Cell Death Dis. 2013;4(12):e950\u2013950.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4926_CR102","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2011.10.002","volume":"315","author":"W Zhu","year":"2012","unstructured":"Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett. 2012;315(1):28\u201337.","journal-title":"Cancer Lett"},{"issue":"6","key":"4926_CR103","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1159\/000479998","volume":"42","author":"J Qi","year":"2017","unstructured":"Qi J, Zhou Y, Jiao Z, Wang X, Zhao Y, Li Y, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth through Hedgehog signaling pathway. Cell Physiol Biochem. 2017;42(6):2242\u201354.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"4926_CR104","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau J, Sens\u00e9b\u00e9 L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824\u201333.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"4926_CR105","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/jcm8122102","volume":"8","author":"E Iacobaeus","year":"2019","unstructured":"Iacobaeus E, Kadri N, Lefsihane K, Boberg E, Gavin C, T\u00f6rnqvist Andr\u00e9n A, et al. Short and long term clinical and Immunologic follow up after bone marrow mesenchymal stromal cell therapy in progressive multiple Sclerosis-A phase I study. J Clin Med. 2019;8(12):2102.","journal-title":"J Clin Med"},{"issue":"3","key":"4926_CR106","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/imm.12518","volume":"146","author":"MA Ali","year":"2015","unstructured":"Ali MA, Thrower SL, Hanna SJ, Coulman SA, Birchall JC, Wong FS, et al. Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin. Immunology. 2015;146(3):411\u201322.","journal-title":"Immunology"},{"issue":"7","key":"4926_CR107","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s13555-025-01421-2","volume":"15","author":"S Gregoire","year":"2025","unstructured":"Gregoire S, McIntosh B, Sanchez K, Biba U, Mostaghimi A. Local corticosteroids for alopecia areata: a narrative review. Dermatol Ther (Heidelb). 2025;15(7):1607\u201331.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"4926_CR108","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00403-021-02201-6","volume":"314","author":"D Metwally","year":"2022","unstructured":"Metwally D, Abdel-Fattah R, Hilal RF. Comparative study for treatment of alopecia areata using carboxy therapy, intralesional corticosteroids, and a combination of both. Arch Dermatol Res. 2022;314(2):167\u201382.","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"4926_CR109","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/exd.12918","volume":"25","author":"J Fuentes-Duculan","year":"2016","unstructured":"Fuentes-Duculan J, Gulati N, Bonifacio KM, Kunjravia N, Zheng X, Su\u00e1rez-Fari\u00f1as M, et al. Biomarkers of alopecia areata disease activity and response to corticosteroid treatment. Exp Dermatol. 2016;25(4):282\u20136.","journal-title":"Exp Dermatol"},{"issue":"7","key":"4926_CR110","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41590-022-01244-9","volume":"23","author":"Z Liu","year":"2022","unstructured":"Liu Z, Hu X, Liang Y, Yu J, Li H, Shokhirev MN, et al. Glucocorticoid signaling and regulatory T cells cooperate to maintain the hair-follicle stem-cell niche. Nat Immunol. 2022;23(7):1086\u201397.","journal-title":"Nat Immunol"},{"key":"4926_CR111","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1196\/annals.1321.010","volume":"1024","author":"IJ Elenkov","year":"2004","unstructured":"Elenkov IJ. Glucocorticoids and the Th1\/Th2 balance. Ann N Y Acad Sci. 2004;1024:138\u201346.","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"4926_CR112","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.4049\/jimmunol.170.9.4833","volume":"170","author":"X Hu","year":"2003","unstructured":"Hu X, Li WP, Meng C, Ivashkiv LB. Inhibition of IFN-gamma signaling by glucocorticoids. J Immunol. 2003;170(9):4833\u20139.","journal-title":"J Immunol"},{"issue":"2","key":"4926_CR113","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1634\/stemcells.2005-0008","volume":"24","author":"M Krampera","year":"2006","unstructured":"Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, et al. Role for interferon-gamma in the Immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24(2):386\u201398.","journal-title":"Stem Cells"},{"key":"4926_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/srep04645","volume":"4","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Dastidar RG, Ong JF, Levy O, Karp JM. Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids. Sci Rep. 2014;4:4645.","journal-title":"Sci Rep"},{"issue":"9","key":"4926_CR115","doi-asserted-by":"publisher","first-page":"922","DOI":"10.4252\/wjsc.v12.i9.922","volume":"12","author":"A Jaukovi\u0107","year":"2020","unstructured":"Jaukovi\u0107 A, Kukolj T, Obradovi\u0107 H, Oki\u0107-\u0110or\u0111evi\u0107 I, Mojsilovi\u0107 S, Bugarski D. Inflammatory niche: mesenchymal stromal cell priming by soluble mediators. World J Stem Cells. 2020;12(9):922\u201337.","journal-title":"World J Stem Cells"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-04926-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04926-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-04926-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:03:05Z","timestamp":1773399785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-04926-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":115,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4926"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-04926-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}